MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceuticals _ Orphan & Rare Diseases
Molecular Insight Pharmaceuticals, Inc
Finance & Acquisitions: Molecular Insights
IPO (2007)
Rosetta Genomics (NASDAQ:ROSG)
Parents
*Architects: Biotechnology_DNA, RNA, RNAi, siRNA & mRNA
*Architects: Molecular Diagnostics
*Industry: Israel
IPO (2007)
Children
2016: Biotech Forum Daily Digest: OPKO Gets Early FDA Approval, Zika Virus Again In The News, Spotlight On XBiotech
First commercial entity to focus on the emerging field of microRNA
North New Brunswick, New Jersey
Rehovot, Israel
Rosetta Genomics Closes on Public Offering, Raises $27.5M (2012)
Rosetta Genomics cutting 35 jobs, Philadelphia impact unclear (2011)
Rosetta is actively advancing multiple internal programs in microRNA diagnostic and therapeutic product development
Jumps
Dr Robert Langer, Phd, Germeshausen Professor of Chemical & Biomedical Engineering, David H. Koch Institute, MIT (2026)